ITCI - Intra-Cellular Therapies Q1 2023 Earnings Preview
2023-05-03 13:39:31 ET
- Intra-Cellular Therapies ( NASDAQ: ITCI ) is scheduled to announce Q1 earnings results on Thursday, May 4th, before market open.
- The consensus EPS Estimate is -$0.62 (+20.5% Y/Y) and the consensus Revenue Estimate is $92.41M (+164.0% Y/Y).
- Over the last 1 year, ITCI has beaten EPS estimates 25% of the time and has beaten revenue estimates 100% of the time.
- Over the last 3 months, EPS estimates have seen 3 upward revisions and 3 downward. Revenue estimates have seen 3 upward revisions and 5 downward.
For further details see:
Intra-Cellular Therapies Q1 2023 Earnings Preview